Trial Profile
A double blind randomised controlled trial examining the effect of intravenous zoledronic acid on pleural fluid production, breathlessness and quality of life in patients with a malignant pleural effusion.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Lung cancer
- Focus Pharmacodynamics
- 30 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 20 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 20 Jun 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network record.